November sees the release of the World Malaria Report, and here we take a look at the key facts and figures.
Researchers have demonstrated that mice previously infected with dengue have protection against Zika virus that appears to be conferred by cytotoxic T cells.
Research presented at ASTMH has demonstrated long-term neurological damage in those with a history of West Nile virus infection, even in individuals who experienced mild, or no, symptoms.
Researchers have discovered that individuals infected with malaria exhale specific compounds, which could be used to rapidly and accurately diagnose the disease.
Blood samples from US athletes and staff who travelled to Rio de Janeiro, Brazil, for the 2016 Summer Games were not infected with Zika virus but tested positive for other viral infections, including West Nile Virus, dengue and chikungunya.
Magnus Evander gives past, present and future perspectives on Inkoo virus – a mosquito-borne virus in northern Europe causing fever and meningoencephalitis.
Missed out on attending the British Society for Parasitology’s Autumn Symposium? Read our report of the event here, including talks from Roy Anderson and David Molyneux.
A new DNA-based Zika vaccine, GLS-5700, has been reported as safe and immunogenic in Phase I trial, according to new research.
Researchers have discovered that antibodies taken from dengue virus infected individuals are effective in treating Zika infection – a closely related flavivirus – in rodents.
The spread of a single multi-drug resistant Plasmodium falciparum lineage to south Vietnam has caused alarm after worrying treatment failure rates. Researchers suggest this presents a serious concern for malaria control efforts.